nodes	percent_of_prediction	percent_of_DWPC	metapath
Acebutolol—ABCB1—Dactinomycin—sarcoma	0.137	0.262	CbGbCtD
Acebutolol—ABCB1—Mitoxantrone—sarcoma	0.122	0.234	CbGbCtD
Acebutolol—ABCB1—Vincristine—sarcoma	0.0843	0.161	CbGbCtD
Acebutolol—ABCB1—Etoposide—sarcoma	0.0772	0.148	CbGbCtD
Acebutolol—ABCB1—Doxorubicin—sarcoma	0.0527	0.101	CbGbCtD
Acebutolol—CYP2D6—Doxorubicin—sarcoma	0.0496	0.0949	CbGbCtD
Acebutolol—Anorexia—Mitoxantrone—sarcoma	0.0012	0.00251	CcSEcCtD
Acebutolol—Pain in extremity—Epirubicin—sarcoma	0.00119	0.0025	CcSEcCtD
Acebutolol—Feeling abnormal—Dactinomycin—sarcoma	0.00119	0.00249	CcSEcCtD
Acebutolol—Gastrointestinal pain—Thiotepa—sarcoma	0.00119	0.00249	CcSEcCtD
Acebutolol—Ill-defined disorder—Etoposide—sarcoma	0.00119	0.00249	CcSEcCtD
Acebutolol—Gastrointestinal pain—Dactinomycin—sarcoma	0.00118	0.00248	CcSEcCtD
Acebutolol—Hot flush—Doxorubicin—sarcoma	0.00118	0.00247	CcSEcCtD
Acebutolol—Musculoskeletal discomfort—Vincristine—sarcoma	0.00118	0.00246	CcSEcCtD
Acebutolol—Hypotension—Mitoxantrone—sarcoma	0.00117	0.00246	CcSEcCtD
Acebutolol—Affect lability—Epirubicin—sarcoma	0.00117	0.00246	CcSEcCtD
Acebutolol—Dermatitis exfoliative—Doxorubicin—sarcoma	0.00117	0.00245	CcSEcCtD
Acebutolol—Menopausal symptoms—Doxorubicin—sarcoma	0.00117	0.00245	CcSEcCtD
Acebutolol—Insomnia—Vincristine—sarcoma	0.00117	0.00245	CcSEcCtD
Acebutolol—Paraesthesia—Vincristine—sarcoma	0.00116	0.00243	CcSEcCtD
Acebutolol—Urticaria—Thiotepa—sarcoma	0.00116	0.00242	CcSEcCtD
Acebutolol—Malaise—Etoposide—sarcoma	0.00115	0.00242	CcSEcCtD
Acebutolol—Vertigo—Etoposide—sarcoma	0.00115	0.00241	CcSEcCtD
Acebutolol—Abdominal pain—Thiotepa—sarcoma	0.00115	0.00241	CcSEcCtD
Acebutolol—Body temperature increased—Thiotepa—sarcoma	0.00115	0.00241	CcSEcCtD
Acebutolol—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.00114	0.0024	CcSEcCtD
Acebutolol—Abdominal pain—Dactinomycin—sarcoma	0.00114	0.00239	CcSEcCtD
Acebutolol—Body temperature increased—Dactinomycin—sarcoma	0.00114	0.00239	CcSEcCtD
Acebutolol—Cardiac failure—Doxorubicin—sarcoma	0.00113	0.00237	CcSEcCtD
Acebutolol—Mood swings—Epirubicin—sarcoma	0.00113	0.00237	CcSEcCtD
Acebutolol—Paraesthesia—Mitoxantrone—sarcoma	0.00113	0.00237	CcSEcCtD
Acebutolol—Loss of consciousness—Etoposide—sarcoma	0.00113	0.00236	CcSEcCtD
Acebutolol—Lethargy—Doxorubicin—sarcoma	0.00113	0.00236	CcSEcCtD
Acebutolol—Decreased appetite—Vincristine—sarcoma	0.00112	0.00235	CcSEcCtD
Acebutolol—Dyspnoea—Mitoxantrone—sarcoma	0.00112	0.00235	CcSEcCtD
Acebutolol—Cough—Etoposide—sarcoma	0.00112	0.00234	CcSEcCtD
Acebutolol—Somnolence—Mitoxantrone—sarcoma	0.00112	0.00234	CcSEcCtD
Acebutolol—Gastrointestinal disorder—Vincristine—sarcoma	0.00111	0.00233	CcSEcCtD
Acebutolol—Fatigue—Vincristine—sarcoma	0.00111	0.00233	CcSEcCtD
Acebutolol—Dyspepsia—Mitoxantrone—sarcoma	0.00111	0.00232	CcSEcCtD
Acebutolol—Pain—Vincristine—sarcoma	0.0011	0.00231	CcSEcCtD
Acebutolol—Constipation—Vincristine—sarcoma	0.0011	0.00231	CcSEcCtD
Acebutolol—Pain in extremity—Doxorubicin—sarcoma	0.0011	0.00231	CcSEcCtD
Acebutolol—Decreased appetite—Mitoxantrone—sarcoma	0.00109	0.00229	CcSEcCtD
Acebutolol—Chest pain—Etoposide—sarcoma	0.00109	0.00229	CcSEcCtD
Acebutolol—Orthostatic hypotension—Epirubicin—sarcoma	0.00109	0.00228	CcSEcCtD
Acebutolol—Affect lability—Doxorubicin—sarcoma	0.00109	0.00228	CcSEcCtD
Acebutolol—Fatigue—Mitoxantrone—sarcoma	0.00108	0.00227	CcSEcCtD
Acebutolol—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.00108	0.00227	CcSEcCtD
Acebutolol—Discomfort—Etoposide—sarcoma	0.00108	0.00226	CcSEcCtD
Acebutolol—Pain—Mitoxantrone—sarcoma	0.00107	0.00225	CcSEcCtD
Acebutolol—Constipation—Mitoxantrone—sarcoma	0.00107	0.00225	CcSEcCtD
Acebutolol—Aspartate aminotransferase increased—Epirubicin—sarcoma	0.00107	0.00225	CcSEcCtD
Acebutolol—Gastrointestinal pain—Vincristine—sarcoma	0.00105	0.00221	CcSEcCtD
Acebutolol—Confusional state—Etoposide—sarcoma	0.00105	0.00221	CcSEcCtD
Acebutolol—Mood swings—Doxorubicin—sarcoma	0.00104	0.00219	CcSEcCtD
Acebutolol—Asthenia—Thiotepa—sarcoma	0.00104	0.00219	CcSEcCtD
Acebutolol—Asthenia—Dactinomycin—sarcoma	0.00104	0.00217	CcSEcCtD
Acebutolol—Feeling abnormal—Mitoxantrone—sarcoma	0.00104	0.00217	CcSEcCtD
Acebutolol—Pruritus—Thiotepa—sarcoma	0.00103	0.00216	CcSEcCtD
Acebutolol—Gastrointestinal pain—Mitoxantrone—sarcoma	0.00103	0.00215	CcSEcCtD
Acebutolol—Abdominal pain—Vincristine—sarcoma	0.00102	0.00214	CcSEcCtD
Acebutolol—Body temperature increased—Vincristine—sarcoma	0.00102	0.00214	CcSEcCtD
Acebutolol—Skin disorder—Etoposide—sarcoma	0.00101	0.00213	CcSEcCtD
Acebutolol—Hyperhidrosis—Etoposide—sarcoma	0.00101	0.00212	CcSEcCtD
Acebutolol—Orthostatic hypotension—Doxorubicin—sarcoma	0.00101	0.00211	CcSEcCtD
Acebutolol—Urticaria—Mitoxantrone—sarcoma	0.000998	0.00209	CcSEcCtD
Acebutolol—Anorexia—Etoposide—sarcoma	0.000996	0.00209	CcSEcCtD
Acebutolol—Diarrhoea—Thiotepa—sarcoma	0.000995	0.00209	CcSEcCtD
Acebutolol—Abdominal pain—Mitoxantrone—sarcoma	0.000993	0.00208	CcSEcCtD
Acebutolol—Body temperature increased—Mitoxantrone—sarcoma	0.000993	0.00208	CcSEcCtD
Acebutolol—Aspartate aminotransferase increased—Doxorubicin—sarcoma	0.000993	0.00208	CcSEcCtD
Acebutolol—Diarrhoea—Dactinomycin—sarcoma	0.000988	0.00207	CcSEcCtD
Acebutolol—Hypotension—Etoposide—sarcoma	0.000976	0.00205	CcSEcCtD
Acebutolol—Dysuria—Epirubicin—sarcoma	0.000963	0.00202	CcSEcCtD
Acebutolol—Dizziness—Thiotepa—sarcoma	0.000962	0.00202	CcSEcCtD
Acebutolol—Paraesthesia—Etoposide—sarcoma	0.000938	0.00197	CcSEcCtD
Acebutolol—Weight increased—Epirubicin—sarcoma	0.000937	0.00197	CcSEcCtD
Acebutolol—Dyspnoea—Etoposide—sarcoma	0.000931	0.00195	CcSEcCtD
Acebutolol—Somnolence—Etoposide—sarcoma	0.000929	0.00195	CcSEcCtD
Acebutolol—Asthenia—Vincristine—sarcoma	0.000925	0.00194	CcSEcCtD
Acebutolol—Vomiting—Thiotepa—sarcoma	0.000925	0.00194	CcSEcCtD
Acebutolol—Pneumonia—Epirubicin—sarcoma	0.000924	0.00194	CcSEcCtD
Acebutolol—Drowsiness—Epirubicin—sarcoma	0.000918	0.00193	CcSEcCtD
Acebutolol—Vomiting—Dactinomycin—sarcoma	0.000918	0.00192	CcSEcCtD
Acebutolol—Rash—Thiotepa—sarcoma	0.000917	0.00192	CcSEcCtD
Acebutolol—Dermatitis—Thiotepa—sarcoma	0.000916	0.00192	CcSEcCtD
Acebutolol—Headache—Thiotepa—sarcoma	0.000911	0.00191	CcSEcCtD
Acebutolol—Rash—Dactinomycin—sarcoma	0.00091	0.00191	CcSEcCtD
Acebutolol—Decreased appetite—Etoposide—sarcoma	0.000908	0.0019	CcSEcCtD
Acebutolol—Gastrointestinal disorder—Etoposide—sarcoma	0.000902	0.00189	CcSEcCtD
Acebutolol—Asthenia—Mitoxantrone—sarcoma	0.000901	0.00189	CcSEcCtD
Acebutolol—Fatigue—Etoposide—sarcoma	0.000901	0.00189	CcSEcCtD
Acebutolol—Constipation—Etoposide—sarcoma	0.000893	0.00187	CcSEcCtD
Acebutolol—Pain—Etoposide—sarcoma	0.000893	0.00187	CcSEcCtD
Acebutolol—Conjunctivitis—Epirubicin—sarcoma	0.000893	0.00187	CcSEcCtD
Acebutolol—Dysuria—Doxorubicin—sarcoma	0.000891	0.00187	CcSEcCtD
Acebutolol—Diarrhoea—Vincristine—sarcoma	0.000882	0.00185	CcSEcCtD
Acebutolol—Sweating—Epirubicin—sarcoma	0.00088	0.00185	CcSEcCtD
Acebutolol—Weight increased—Doxorubicin—sarcoma	0.000867	0.00182	CcSEcCtD
Acebutolol—Nausea—Thiotepa—sarcoma	0.000864	0.00181	CcSEcCtD
Acebutolol—Feeling abnormal—Etoposide—sarcoma	0.000861	0.00181	CcSEcCtD
Acebutolol—Diarrhoea—Mitoxantrone—sarcoma	0.000859	0.0018	CcSEcCtD
Acebutolol—Nausea—Dactinomycin—sarcoma	0.000857	0.0018	CcSEcCtD
Acebutolol—Agranulocytosis—Epirubicin—sarcoma	0.000857	0.0018	CcSEcCtD
Acebutolol—Pneumonia—Doxorubicin—sarcoma	0.000855	0.00179	CcSEcCtD
Acebutolol—Gastrointestinal pain—Etoposide—sarcoma	0.000854	0.00179	CcSEcCtD
Acebutolol—Dizziness—Vincristine—sarcoma	0.000853	0.00179	CcSEcCtD
Acebutolol—Drowsiness—Doxorubicin—sarcoma	0.00085	0.00178	CcSEcCtD
Acebutolol—Bradycardia—Epirubicin—sarcoma	0.000839	0.00176	CcSEcCtD
Acebutolol—Urticaria—Etoposide—sarcoma	0.00083	0.00174	CcSEcCtD
Acebutolol—Rhinitis—Epirubicin—sarcoma	0.000826	0.00173	CcSEcCtD
Acebutolol—Body temperature increased—Etoposide—sarcoma	0.000826	0.00173	CcSEcCtD
Acebutolol—Abdominal pain—Etoposide—sarcoma	0.000826	0.00173	CcSEcCtD
Acebutolol—Conjunctivitis—Doxorubicin—sarcoma	0.000826	0.00173	CcSEcCtD
Acebutolol—Hypoaesthesia—Epirubicin—sarcoma	0.00082	0.00172	CcSEcCtD
Acebutolol—Vomiting—Vincristine—sarcoma	0.00082	0.00172	CcSEcCtD
Acebutolol—Pharyngitis—Epirubicin—sarcoma	0.000818	0.00172	CcSEcCtD
Acebutolol—Sweating—Doxorubicin—sarcoma	0.000815	0.00171	CcSEcCtD
Acebutolol—Rash—Vincristine—sarcoma	0.000813	0.00171	CcSEcCtD
Acebutolol—Dermatitis—Vincristine—sarcoma	0.000812	0.0017	CcSEcCtD
Acebutolol—Connective tissue disorder—Epirubicin—sarcoma	0.00081	0.0017	CcSEcCtD
Acebutolol—Headache—Vincristine—sarcoma	0.000808	0.00169	CcSEcCtD
Acebutolol—Vomiting—Mitoxantrone—sarcoma	0.000799	0.00167	CcSEcCtD
Acebutolol—Visual impairment—Epirubicin—sarcoma	0.000794	0.00167	CcSEcCtD
Acebutolol—Agranulocytosis—Doxorubicin—sarcoma	0.000793	0.00166	CcSEcCtD
Acebutolol—Rash—Mitoxantrone—sarcoma	0.000792	0.00166	CcSEcCtD
Acebutolol—Dermatitis—Mitoxantrone—sarcoma	0.000791	0.00166	CcSEcCtD
Acebutolol—Headache—Mitoxantrone—sarcoma	0.000787	0.00165	CcSEcCtD
Acebutolol—Bradycardia—Doxorubicin—sarcoma	0.000777	0.00163	CcSEcCtD
Acebutolol—Tinnitus—Epirubicin—sarcoma	0.000769	0.00161	CcSEcCtD
Acebutolol—Nausea—Vincristine—sarcoma	0.000766	0.00161	CcSEcCtD
Acebutolol—Flushing—Epirubicin—sarcoma	0.000765	0.0016	CcSEcCtD
Acebutolol—Rhinitis—Doxorubicin—sarcoma	0.000765	0.0016	CcSEcCtD
Acebutolol—Hypoaesthesia—Doxorubicin—sarcoma	0.000759	0.00159	CcSEcCtD
Acebutolol—Pharyngitis—Doxorubicin—sarcoma	0.000757	0.00159	CcSEcCtD
Acebutolol—Asthenia—Etoposide—sarcoma	0.00075	0.00157	CcSEcCtD
Acebutolol—Connective tissue disorder—Doxorubicin—sarcoma	0.00075	0.00157	CcSEcCtD
Acebutolol—Angiopathy—Epirubicin—sarcoma	0.000748	0.00157	CcSEcCtD
Acebutolol—Nausea—Mitoxantrone—sarcoma	0.000746	0.00156	CcSEcCtD
Acebutolol—Mediastinal disorder—Epirubicin—sarcoma	0.000743	0.00156	CcSEcCtD
Acebutolol—Chills—Epirubicin—sarcoma	0.00074	0.00155	CcSEcCtD
Acebutolol—Pruritus—Etoposide—sarcoma	0.000739	0.00155	CcSEcCtD
Acebutolol—Visual impairment—Doxorubicin—sarcoma	0.000735	0.00154	CcSEcCtD
Acebutolol—Alopecia—Epirubicin—sarcoma	0.000728	0.00153	CcSEcCtD
Acebutolol—Diarrhoea—Etoposide—sarcoma	0.000715	0.0015	CcSEcCtD
Acebutolol—Tinnitus—Doxorubicin—sarcoma	0.000711	0.00149	CcSEcCtD
Acebutolol—Flushing—Doxorubicin—sarcoma	0.000708	0.00148	CcSEcCtD
Acebutolol—Flatulence—Epirubicin—sarcoma	0.000707	0.00148	CcSEcCtD
Acebutolol—Back pain—Epirubicin—sarcoma	0.000694	0.00146	CcSEcCtD
Acebutolol—Angiopathy—Doxorubicin—sarcoma	0.000692	0.00145	CcSEcCtD
Acebutolol—Dizziness—Etoposide—sarcoma	0.000691	0.00145	CcSEcCtD
Acebutolol—Mediastinal disorder—Doxorubicin—sarcoma	0.000687	0.00144	CcSEcCtD
Acebutolol—Chills—Doxorubicin—sarcoma	0.000684	0.00144	CcSEcCtD
Acebutolol—Vision blurred—Epirubicin—sarcoma	0.000676	0.00142	CcSEcCtD
Acebutolol—Alopecia—Doxorubicin—sarcoma	0.000674	0.00141	CcSEcCtD
Acebutolol—Ill-defined disorder—Epirubicin—sarcoma	0.000666	0.0014	CcSEcCtD
Acebutolol—Vomiting—Etoposide—sarcoma	0.000664	0.00139	CcSEcCtD
Acebutolol—Rash—Etoposide—sarcoma	0.000659	0.00138	CcSEcCtD
Acebutolol—Dermatitis—Etoposide—sarcoma	0.000658	0.00138	CcSEcCtD
Acebutolol—Headache—Etoposide—sarcoma	0.000655	0.00137	CcSEcCtD
Acebutolol—Flatulence—Doxorubicin—sarcoma	0.000654	0.00137	CcSEcCtD
Acebutolol—Malaise—Epirubicin—sarcoma	0.000647	0.00136	CcSEcCtD
Acebutolol—Vertigo—Epirubicin—sarcoma	0.000645	0.00135	CcSEcCtD
Acebutolol—Syncope—Epirubicin—sarcoma	0.000644	0.00135	CcSEcCtD
Acebutolol—Back pain—Doxorubicin—sarcoma	0.000642	0.00135	CcSEcCtD
Acebutolol—Palpitations—Epirubicin—sarcoma	0.000634	0.00133	CcSEcCtD
Acebutolol—Loss of consciousness—Epirubicin—sarcoma	0.000631	0.00132	CcSEcCtD
Acebutolol—Cough—Epirubicin—sarcoma	0.000626	0.00131	CcSEcCtD
Acebutolol—Vision blurred—Doxorubicin—sarcoma	0.000626	0.00131	CcSEcCtD
Acebutolol—Nausea—Etoposide—sarcoma	0.000621	0.0013	CcSEcCtD
Acebutolol—Ill-defined disorder—Doxorubicin—sarcoma	0.000616	0.00129	CcSEcCtD
Acebutolol—Myalgia—Epirubicin—sarcoma	0.000611	0.00128	CcSEcCtD
Acebutolol—Chest pain—Epirubicin—sarcoma	0.000611	0.00128	CcSEcCtD
Acebutolol—Arthralgia—Epirubicin—sarcoma	0.000611	0.00128	CcSEcCtD
Acebutolol—Anxiety—Epirubicin—sarcoma	0.000609	0.00128	CcSEcCtD
Acebutolol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000607	0.00127	CcSEcCtD
Acebutolol—Discomfort—Epirubicin—sarcoma	0.000604	0.00127	CcSEcCtD
Acebutolol—Malaise—Doxorubicin—sarcoma	0.000599	0.00126	CcSEcCtD
Acebutolol—Vertigo—Doxorubicin—sarcoma	0.000597	0.00125	CcSEcCtD
Acebutolol—Syncope—Doxorubicin—sarcoma	0.000595	0.00125	CcSEcCtD
Acebutolol—Confusional state—Epirubicin—sarcoma	0.000591	0.00124	CcSEcCtD
Acebutolol—Palpitations—Doxorubicin—sarcoma	0.000587	0.00123	CcSEcCtD
Acebutolol—Oedema—Epirubicin—sarcoma	0.000586	0.00123	CcSEcCtD
Acebutolol—Loss of consciousness—Doxorubicin—sarcoma	0.000584	0.00122	CcSEcCtD
Acebutolol—Cough—Doxorubicin—sarcoma	0.000579	0.00121	CcSEcCtD
Acebutolol—Shock—Epirubicin—sarcoma	0.000576	0.00121	CcSEcCtD
Acebutolol—Nervous system disorder—Epirubicin—sarcoma	0.000574	0.0012	CcSEcCtD
Acebutolol—Skin disorder—Epirubicin—sarcoma	0.000569	0.00119	CcSEcCtD
Acebutolol—Hyperhidrosis—Epirubicin—sarcoma	0.000566	0.00119	CcSEcCtD
Acebutolol—Chest pain—Doxorubicin—sarcoma	0.000565	0.00119	CcSEcCtD
Acebutolol—Myalgia—Doxorubicin—sarcoma	0.000565	0.00119	CcSEcCtD
Acebutolol—Arthralgia—Doxorubicin—sarcoma	0.000565	0.00119	CcSEcCtD
Acebutolol—Anxiety—Doxorubicin—sarcoma	0.000563	0.00118	CcSEcCtD
Acebutolol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000561	0.00118	CcSEcCtD
Acebutolol—Discomfort—Doxorubicin—sarcoma	0.000559	0.00117	CcSEcCtD
Acebutolol—Anorexia—Epirubicin—sarcoma	0.000558	0.00117	CcSEcCtD
Acebutolol—Hypotension—Epirubicin—sarcoma	0.000547	0.00115	CcSEcCtD
Acebutolol—Confusional state—Doxorubicin—sarcoma	0.000546	0.00115	CcSEcCtD
Acebutolol—Oedema—Doxorubicin—sarcoma	0.000542	0.00114	CcSEcCtD
Acebutolol—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000534	0.00112	CcSEcCtD
Acebutolol—Shock—Doxorubicin—sarcoma	0.000533	0.00112	CcSEcCtD
Acebutolol—Nervous system disorder—Doxorubicin—sarcoma	0.000531	0.00111	CcSEcCtD
Acebutolol—Insomnia—Epirubicin—sarcoma	0.00053	0.00111	CcSEcCtD
Acebutolol—Skin disorder—Doxorubicin—sarcoma	0.000526	0.0011	CcSEcCtD
Acebutolol—Paraesthesia—Epirubicin—sarcoma	0.000526	0.0011	CcSEcCtD
Acebutolol—Hyperhidrosis—Doxorubicin—sarcoma	0.000524	0.0011	CcSEcCtD
Acebutolol—Dyspnoea—Epirubicin—sarcoma	0.000522	0.00109	CcSEcCtD
Acebutolol—Somnolence—Epirubicin—sarcoma	0.000521	0.00109	CcSEcCtD
Acebutolol—Anorexia—Doxorubicin—sarcoma	0.000517	0.00108	CcSEcCtD
Acebutolol—Dyspepsia—Epirubicin—sarcoma	0.000516	0.00108	CcSEcCtD
Acebutolol—Decreased appetite—Epirubicin—sarcoma	0.000509	0.00107	CcSEcCtD
Acebutolol—Hypotension—Doxorubicin—sarcoma	0.000506	0.00106	CcSEcCtD
Acebutolol—Gastrointestinal disorder—Epirubicin—sarcoma	0.000506	0.00106	CcSEcCtD
Acebutolol—Fatigue—Epirubicin—sarcoma	0.000505	0.00106	CcSEcCtD
Acebutolol—Pain—Epirubicin—sarcoma	0.000501	0.00105	CcSEcCtD
Acebutolol—Constipation—Epirubicin—sarcoma	0.000501	0.00105	CcSEcCtD
Acebutolol—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000494	0.00104	CcSEcCtD
Acebutolol—Insomnia—Doxorubicin—sarcoma	0.00049	0.00103	CcSEcCtD
Acebutolol—Paraesthesia—Doxorubicin—sarcoma	0.000487	0.00102	CcSEcCtD
Acebutolol—Dyspnoea—Doxorubicin—sarcoma	0.000483	0.00101	CcSEcCtD
Acebutolol—Feeling abnormal—Epirubicin—sarcoma	0.000483	0.00101	CcSEcCtD
Acebutolol—Somnolence—Doxorubicin—sarcoma	0.000482	0.00101	CcSEcCtD
Acebutolol—Gastrointestinal pain—Epirubicin—sarcoma	0.000479	0.001	CcSEcCtD
Acebutolol—Dyspepsia—Doxorubicin—sarcoma	0.000477	0.001	CcSEcCtD
Acebutolol—Decreased appetite—Doxorubicin—sarcoma	0.000471	0.000988	CcSEcCtD
Acebutolol—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000468	0.000981	CcSEcCtD
Acebutolol—Fatigue—Doxorubicin—sarcoma	0.000467	0.00098	CcSEcCtD
Acebutolol—Urticaria—Epirubicin—sarcoma	0.000465	0.000976	CcSEcCtD
Acebutolol—Pain—Doxorubicin—sarcoma	0.000463	0.000972	CcSEcCtD
Acebutolol—Constipation—Doxorubicin—sarcoma	0.000463	0.000972	CcSEcCtD
Acebutolol—Body temperature increased—Epirubicin—sarcoma	0.000463	0.000971	CcSEcCtD
Acebutolol—Abdominal pain—Epirubicin—sarcoma	0.000463	0.000971	CcSEcCtD
Acebutolol—Feeling abnormal—Doxorubicin—sarcoma	0.000447	0.000936	CcSEcCtD
Acebutolol—Gastrointestinal pain—Doxorubicin—sarcoma	0.000443	0.000929	CcSEcCtD
Acebutolol—Urticaria—Doxorubicin—sarcoma	0.000431	0.000903	CcSEcCtD
Acebutolol—Body temperature increased—Doxorubicin—sarcoma	0.000428	0.000898	CcSEcCtD
Acebutolol—Abdominal pain—Doxorubicin—sarcoma	0.000428	0.000898	CcSEcCtD
Acebutolol—Asthenia—Epirubicin—sarcoma	0.00042	0.000881	CcSEcCtD
Acebutolol—Pruritus—Epirubicin—sarcoma	0.000414	0.000869	CcSEcCtD
Acebutolol—Diarrhoea—Epirubicin—sarcoma	0.000401	0.00084	CcSEcCtD
Acebutolol—Asthenia—Doxorubicin—sarcoma	0.000389	0.000815	CcSEcCtD
Acebutolol—Dizziness—Epirubicin—sarcoma	0.000387	0.000812	CcSEcCtD
Acebutolol—Pruritus—Doxorubicin—sarcoma	0.000383	0.000804	CcSEcCtD
Acebutolol—Vomiting—Epirubicin—sarcoma	0.000372	0.000781	CcSEcCtD
Acebutolol—Diarrhoea—Doxorubicin—sarcoma	0.000371	0.000777	CcSEcCtD
Acebutolol—Rash—Epirubicin—sarcoma	0.000369	0.000774	CcSEcCtD
Acebutolol—Dermatitis—Epirubicin—sarcoma	0.000369	0.000774	CcSEcCtD
Acebutolol—Headache—Epirubicin—sarcoma	0.000367	0.000769	CcSEcCtD
Acebutolol—Dizziness—Doxorubicin—sarcoma	0.000358	0.000751	CcSEcCtD
Acebutolol—Nausea—Epirubicin—sarcoma	0.000348	0.000729	CcSEcCtD
Acebutolol—Vomiting—Doxorubicin—sarcoma	0.000345	0.000722	CcSEcCtD
Acebutolol—Rash—Doxorubicin—sarcoma	0.000342	0.000716	CcSEcCtD
Acebutolol—Dermatitis—Doxorubicin—sarcoma	0.000341	0.000716	CcSEcCtD
Acebutolol—Headache—Doxorubicin—sarcoma	0.000339	0.000712	CcSEcCtD
Acebutolol—Nausea—Doxorubicin—sarcoma	0.000322	0.000675	CcSEcCtD
